LINC-ROR and neoplasm: Interestingly, sorafenib similarly increased lncRNA ROR levels in tumor cells and their EVs, whereas siRNA-mediated lncRNA ROR knockdown restored chemotherapy responsiveness via mechanisms involving diminished CD133+ cells in response to transforming growth factor-β (TGFβ), a known stimulant inducing chemotherapy resistance 99.